Citius pharmaceuticals to participate in maxim group's virtual healthcare conference on june 21, 2023

Cranford, n.j. , june 13, 2023 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that chairman and ceo leonard mazur will participate in a fireside chat with senior biotech research analyst, michael okunewitch, at maxim group's virtual healthcare conference on june 21, 2023.
CTXR Ratings Summary
CTXR Quant Ranking